tert-Butyl 4-(bromomethyl)benzylcarbamate, 95.0%, 250mg

4-BROMO-3-METHYL-7-AZAINDOLE, 95.0%, 10g

1-[2-(dimethylamino)ethyl]-2,3-dihydro-1h-indole-2,3-dione, 95%, 50mg

4-[(methylsulfanyl)methyl]benzonitrile, 95%, 1g

4,5-Dimethyl-4H-1,2,4-triazol-3-amine hydroiodide, 97%, 1g

Tripropilenglicol monobutil éter, min 95%, para síntesis, 5L, envase plástico.

(3R,4S)-1-(tert-Butoxycarbonyl)-4-(naphthalen-1-yl)pyrrolidine-3-carboxylic acid, 95.0%, 250mg

(S)-1-N-Boc-3-Hydroxypiperidine, 98.0%, 25g

D-Glucopyranoside, Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-, tetraacetate, 95%, 1g

4-METHYLMORPHOLINE-2-CARBONITRILE, 95.0%, 250mg

(2R,3S,4S,5R,6R)-2-(Hydroxymethyl)-6-(nonyloxy)tetrahydro-2H-pyran-3,4,5-triol, 95.0%, 250mg

4-Chlorophenylacetone>97.0%(GC)5g

4-CHLORO-3-CYANO-2-FLUOROBENZOIC ACID, 95.0%, 250mg